Kistler-Tiffany Companies’s NRC Health Common Stock NRC Stock Holding History

Kistler-Tiffany Companies’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$8.79K	Hold	202	–	–	﹤0.01%	714
2023 Q1	$8.79K	Hold	202	–	–	﹤0.01%	646
2022 Q4	$7.54K	Hold	202	–	–	﹤0.01%	655
2022 Q3	$8K	Hold	202	–	–	﹤0.01%	628
2022 Q2	$8K	Hold	202	–	–	﹤0.01%	610
2022 Q1	$8K	Hold	202	–	–	﹤0.01%	630
2021 Q4	$8K	Hold	202	–	–	﹤0.01%	618
2021 Q3	$9K	Hold	202	–	–	﹤0.01%	598
2021 Q2	$9K	Hold	202	–	–	﹤0.01%	576
2021 Q1	$9K	Hold	202	–	–	﹤0.01%	533
2020 Q4	$9K	Hold	202	–	–	﹤0.01%	509
2020 Q3	$10K	Hold	202	–	–	﹤0.01%	474
2020 Q2	$12K	Hold	202	–	–	﹤0.01%	427
2020 Q1	$13K	Hold	202	–	–	﹤0.01%	410
2019 Q4	$13K	Hold	202	–	–	﹤0.01%	416
2019 Q3	$12K	Hold	202	–	–	﹤0.01%	431
2019 Q2	$12K	Hold	202	–	–	﹤0.01%	421
2019 Q1	$8K	Hold	202	–	–	﹤0.01%	462
2018 Q4	$8K	Hold	202	–	–	﹤0.01%	434
2018 Q3	$8K	Hold	202	–	–	﹤0.01%	449
2018 Q2	$8K	Hold	202	–	–	﹤0.01%	434
2018 Q1	$6K	Buy	202 +80	+66%	+$2.68K	﹤0.01%	478
2017 Q4	$5K	Buy	122 +57	+88%	+$2.02K	﹤0.01%	473
2017 Q3	$2K	Buy	+65	New	+$2.04K	﹤0.01%	509

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kistler-Tiffany Companies's NRC Position: Q2 2023 in Review

Kistler-Tiffany Companies held its NRC Health Common Stock (NRC) position steady in Q2 2023 at 202 shares worth $8.79K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Kistler-Tiffany Companies first reported a position in NRC in Q3 2017 and has held it in 24 quarters since. The position peaked at $13K in Q1 2020. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

Kistler-Tiffany Companies held 202 shares of NRC Health Common Stock worth $8.79K as of Q2 2023.
Kistler-Tiffany Companies left its NRC Health Common Stock share count unchanged in Q2 2023.
NRC Health Common Stock made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #714 holding.
Kistler-Tiffany Companies first reported a position in NRC Health Common Stock in Q3 2017 and has held it in 24 quarters since.
Kistler-Tiffany Companies's NRC Health Common Stock position peaked at $13K in Q1 2020.
116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.